MEET CONGRESS 2015 - Monday June 8

Monday June 8

08.30	Opening remarks
	M. Amor, N. Cheshire, E. Ducasse, M. Lachat, N. Mangialardi, P. Schneider, I. Van Herzeele

08.35	BTK strategies and best options
	Moderators: R. Ferraresi, A. Sauguet, E. Ducasse

	State of the art of BTK-CLI treatment
	08.35	Arterial status, angiosome, arterial calcifications, is it possible to plan treatment at BTK level? M. Gargiulo
	08.43	Big vessel versus small vessel disease: what is the true cause of critical limb ischemia? R. Ferraresi
	08.51	BTK long lesions: devices and optimaltreatment, R. Ferraresi
	08.59	Insight about ultrasound in planing, access and control of BTK angioplasty, E. Puras Mallagray
	09.07	BTK bifurcations: best treatment, F. Airoldi
	09.15	Discussion
		State of the art:
	09.20	Drug eluting stent in BTK disease, K. Deloose
	09.28	Bare metal stent in BTK disease, E. Ducasse
	09.36	Drug eluting balloon in BTK disease, K. Deloose
	09.44	Distal bypass in BTK disease, P. Schneider
	09.56	Discussion, M. Di Primio

	10.00	Coffee break in the exhibition hall

	Tips & tricks & complications
	10.30	Challenging BTK case, E. Ducasse
	10.40	When coronary devices could help? A. Sauguet
	10.50	Below-the-ankle angioplasty and stenting for CLI, J. Brunet
	11.00	Extreme distal revascularization with conventional and alternative techniques, M. Di Primio
	11.10	Discussion

11.20	Thoracic pathology
	Moderators: S. Ronchey, F. Veith, A. Bray

	How I deal with the aortic arch: from planning to follow-up
	11.20	My experience in ascending aorta TEVAR, I. Loftus
	11.28	Open surgery conventional: discrepancy in results (lights and shadow), D. Pacini
	11.36	Ascending aorta: is the endovascular approach realistic? T. Kölbel
	11.44	Off the shelf solution: selection based on planning, N. Mangialardi
	11.52	My planing for arch Chimney, J. Brunkwall
	12.00	Endoleak after arch Chimney, R. Kolvenbach
	12.08	Hybrid repair: technique for total debranching, P. Bergeron
	12.16	Stroke rate and mortality in arch procedures, M. Lachat
	12.24	Endovascular arch repair following ascending aorta open surgery, T. Kölbel
	12.32	Complications of supraaortic debranching, S. Ronchey
	12.40	Demonstration (crazy arch case), T. Larzon
	12.48	Discussion

	13.00	Buffet lunch served on the rooftop, coffee served in the exhibition hall

14.00	Thoracic pathology
	Moderators: J. Busquet, F. Veith, M. Lachat, N. Mangialardi

	Dissection
	14.00	We do treat all - and why, N. Cheshire
	14.08	I do treat when appropriate, J. Steuer
	14.16	The false channel occlusion technique, T. Kölbel
	14.24	TEVAR for chronic dissection, I. Loftus
	14.32	News from imaging will change our attitude, L. Maene
	14.40	Discussion

	Descending aorta
	14.50	TEVAR European guidelines, V. Riambau
	14.58	How I fix endoleak in TEVAR, P. Kasprzak
	15.06	Clampless sutured anastomosis technique, Z. Rancic
	15.14	Long-term results for TEVAR after BAI, R. Vallabhaneni
	15.22	Access vessels challenges and best access route, F. Setacci
	15.30	Discussion

15.45	Highly complex lesions in femo/pop. What do I learn from my daily practice ?

	15.45	Clinical case review, J. Brunet
	15.57	Clinical case review, M. Amor
	16.09	Discussion

	16.15	Coffee break in the exhibition hall

16.45	Femoropopliteal disease - Part 1
	Moderators: Y. Gouëffic, K. Deloose, P. Schneider, C. Setacci

	Strategy
	16.45	Anti-platelet therapy: who needs it and what to prescribe, K. Deloose
	16.53	Popliteal artery aneurysm - What is the best mode of treatment? T. Schmitz Rixen
	17.01	Radial access for femoropopliteal lesions: tips and tricks, R. Coscas
	17.09	Closure devices: treatment of complications, J. Van Den Berg
	17.18	Discussion

	TASC A/B femoropopliteal lesions
	17.20	Is connected stent the good option for TASC A/B SFA lesions? E. Ducasse
	17.30	Discussion
		Debate. TASC A/B femoropopliteal lesions treatment
		17.35 Stent should be the first line treatment, J-P. de Vries
		17.43 Two-year results of a low-dose drug-coated balloon for revascularization of the femoropopliteal artery (ILLUMENATE FIH Trial), Y. Gouëffic
		17.51 DES should be the first line treatment, J. Van Den Berg
		17.59 Discussion
	18.05	Are current stents ready for the « surgical landing-zones »? L. Maene
	18.13	Lecture from China: Selective stent placement versus balloon angioplasty for renovascular hypertension caused by Takayasu Arteritis: two-year results, X. Jiang
	18.21	End of the sessions